Compounds > n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine
Page last updated: 2024-09-03

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and pioglitazone

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with pioglitazone in 1 studies

Compound Research Comparison

Studies
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Trials
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Recent Studies (post-2010)
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)		Studies
(pioglitazone)		Trials
(pioglitazone)		Recent Studies (post-2010) (pioglitazone)
2145584,3388242,277

Protein Interaction Comparison

ProteinTaxonomyn(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50)pioglitazone (IC50)
CDGSH iron-sulfur domain-containing protein 1Rattus norvegicus (Norway rat)1
Bile salt export pumpRattus norvegicus (Norway rat)2
Peroxisome proliferator-activated receptor gammaRattus norvegicus (Norway rat)0.7
Bile salt export pumpHomo sapiens (human)0.337
Carbonic anhydrase 2Homo sapiens (human)0.114
Steryl-sulfataseHomo sapiens (human)0.8
Peroxisome proliferator-activated receptor alphaMus musculus (house mouse)1.15
Amine oxidase [flavin-containing] BHomo sapiens (human)0.298
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)3.0379
Peroxisome proliferator-activated receptor gammaMus musculus (house mouse)0.7
CDGSH iron-sulfur domain-containing protein 2Homo sapiens (human)4.8
CDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)8.65

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ahn, S; An, S; Choi, H; Jeong, LS; Ko, H; Noh, M; Pyo, JJ; Shin, JC; Yu, J1

Other Studies

1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and pioglitazone

ArticleYear
Selenium bioisosteric replacement of adenosine derivatives promoting adiponectin secretion increases the binding affinity to peroxisome proliferator-activated receptor δ.
    Bioorganic & medicinal chemistry, 2020, 01-01, Volume: 28, Issue:1

    Topics: Adenosine; Adiponectin; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Mesenchymal Stem Cells; Molecular Docking Simulation; Molecular Structure; PPAR delta; Selenium; Structure-Activity Relationship

2020